OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model

Author： Tsimafeyeu Ilya   Zaveleva Elina   Stepanova Evgenia   Low Walter  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.31, Iss.6, 2013-12, pp. : 1436-1443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Synergistic Effect of Humanized Monoclonal Antibodies Targeting Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Chemotherapy

By  

Current Drug Targets, Vol. 15, Iss. 7, 2014-06 ,pp. : 674-680

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies Targeting the Epidermal Growth Factor Receptor

By  

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 275-287

Bentham Science Publishers

Access to resources Recommend Favorite

Cetuximab: an IgG1 monoclonal antibody for the treatment of epidermal growth factor receptor-expressing tumours

By Humblet Yves  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 7, 2004-07 ,pp. : 1621-1633

Informa Healthcare

Access to resources Recommend Favorite

Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy

By Heinzle Christine   Sutterlüüty Hedwig   Grusch Michael   Grasl-Kraupp Bettina   Berger Walter   Marian Brigitte  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 829-846

Informa Healthcare

Access to resources Recommend Favorite

Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?

By Bedussi Francesca   Bottini Alberto   Memo Maurizio   Fox Stephen B   Sigala Sandra   Generali Daniele  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 6, 2014-06 ,pp. : 665-678

Informa Healthcare

Access to resources Recommend Favorite